Medication dosing errors in hospitalized patients with renal impairment: A study in Palestine

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 8, 2007, Pages 908-912

  Sweileh, Waleed M ^a   Janem, Samah A ^a   Sawalha, Ansam F ^a   Abu Taha, Adham S ^a   Zyoud, Sa'ed H ^a   Sabri, Iyad A ^a   Al jabi, Samah W ^a   Jaradat, Nidal A ^a   Zaid, Abed Al Naser M ^a  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

Author keywords

Dose adjustment; Renal impairment

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARDIOVASCULAR AGENT; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; CREATININE; DIGOXIN; METOCLOPRAMIDE; RANITIDINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG DOSE INCREASE; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; KIDNEY METABOLISM; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICATION ERROR; NEPHROTOXICITY; PALESTINE; PATIENT INFORMATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HOSPITAL; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CREATININE; CROSS-SECTIONAL STUDIES; DIGOXIN; FEMALE; HOSPITAL BED CAPACITY, 100 TO 299; HOSPITALS, PUBLIC; HUMANS; ISRAEL; MALE; MEDICATION ERRORS; MIDDLE AGED; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; RANITIDINE; RENAL INSUFFICIENCY;

EID: 34548312504     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1412     Document Type: Article

References (22)

1. Nygaard HA, Naik M, Ruths S, Kruger K. Clinically important renal impairment in various groups of old persons. Scand J Prim Health Care 2004; 22(3): 152-156.
2. Peterson JP, Colucci VJ, Schiff SE. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs. Am J Hosp Pharm 1991; 48: 1962-1964.
3. Goldberg DE, Baardsgaard G, Johnson MT, Jolowsky CM, Shepherd M, Peterson CD. Computer-based program for identifying medication orders requiring dosage modification based on renal function. Am J Hosp Pharm 1991; 48: 1965-1969.
4. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307-311.
5. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301-306.
6. Salomon L, Deray G, Jaudon MC, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care 2003; 15(4): 331-335.
7. Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J 2003; 33(1-2): 10-13. Erratum in: Intern Med J. 2003 Jul;33(7):331.
8. Yap C, Dunham D, Thompson J, Baker D. Medication dosing errors for patients with renal insufficiency in ambulatory care. Jt Comm J Qual Patient Saf 2005; 31(9): 514-521.
9. Theschner W, Vozeh S. Pharmacokinetic drug data. In Avery's Drug Treatment, 4th edn, Speight TM, Holford NHG (eds). Adis International: Auckland, 1997; 1629-1664.
10. Karie S, Launay-Vacher V, Janus N, Izzedine H, Deray G. Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure. Nephrol Dial Transplant 2006; 24: 1516-1520.
11. Blix HS, Viktil KK, Moger TA, Reikvam A. Use of renal risk drugs in hospitalized patients with impaired renal function - an underestimated problem? Nephrol Dial Transplant 2006 Jul 31.
12. Karras DJ. Severe low back pain secondary to acute interstitial nephritis following administration of ranitidine. Am J Emerg Med 1994; 12(1): 67-68.
13. Slugg PH, Haug MT, Pippenger CE. Ranitidine pharmacokinetics and adverse central nervous system reactions. Arch Intern Med 1992; 152: 2325-2329.
14. Amos RJ, Kirk B, Amess JA, Jones AL, Hinds CJ. Bone marrow hypoplasia during intensive care: bone marrow culture studies implicating ranitidine in the suppression of haemopoiesis. Hum Toxicol 1987; 6(6): 503-506.
15. Ma G, Brady WJ, Pollack M. Electrocardiographic manifestations: digitalis toxicity. J Emerg Med 2001; 20: 145-152.
16. Lerner SA, Schmitt BA, Seligsohn R, et al. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am J Med 1986; 80(suppl 6B): 98-104.
17. Bald M, Ratjen F, Nikolaizik W, et al. Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis. Pediatr Infect Dis J 2001; 20(3): 320-321.
18. Connor JP, Curry JM, Selby TL, et al. Acute renal failure secondary to ciprofloxacin use. J Urol 1994; 151: 975-976.
19. Goddard JK, Janning SW, Gass JS. Cefuroxime-induced acute renal failure. Pharmacotherapy 1994; 14: 488-491.
20. Bailey JR, Trott SA, Philbrick JT. Ciprofloxacin-induced acute interstitial nephritis. Am J Nephrol 1992; 12(4): 271-273.
21. Arvieux C, Charasse C, Guilhem I, Rivalan J, Le Pogamp P, Ramee MP. Acute kidney failure due to tubulo-interstitial nephropathy after treatment with ciprofloxacin. Presse Med 1991; 20(34): 1686.
22. Morin JP, Olier B, Viotte G, Grancher G, Paumier JC. The lysosomal toxicity of aminoglycosides: a morphometric approach. Int J Tissue React 1984; 6(5): 472-435.